Wescott Financial Advisory Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Wescott Financial Advisory Group's PFE Position: Q2 2026 in Review
Wescott Financial Advisory Group sold out of Pfizer (PFE) in Q2 2026, closing a stake of 8,914 shares — an estimated $250K sold.
Wescott Financial Advisory Group first reported a position in PFE in Q1 2022 and held it in 14 quarters. The position peaked at $907K in Q2 2022. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Wescott Financial Advisory Group reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
- Wescott Financial Advisory Group sold 8,914 Pfizer shares in Q2 2026, an estimated $250K.
- Wescott Financial Advisory Group first reported a position in Pfizer in Q1 2022 and held it in 14 quarters.
- Wescott Financial Advisory Group's Pfizer position peaked at $907K in Q2 2022.
- 2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Wescott Financial Advisory Group's 13F filing for Q2 2026, filed 4 Aug 2026.